Skip to main content
editor@theusajournals.com | Oscar Publishing Services Journal Home

American Journal Of Biomedical Science & Pharmaceutical Innovation

Peer Reviewed | Open Access | E-ISSN: 2771-2753
Published Article

Multitarget Antithrombotic Effects of Scutellarin On Platelet–Coagulation Hemostasis

Multitarget Antithrombotic Effects of Scutellarin On Platelet–Coagulation Hemostasis

  • Asatillaev Jahongir
    Uzbek State University of Physical Culture and Sport, 111709 Chirchik, Uzbekistan
  • Khoshimov Nozim
    Institute of Biophysics and Biochemistry at the National University of Uzbekistan, 100174 Tashkent, Uzbekistan National University of Uzbekistan named after M. Ulugbek, 100174 Tashkent, Uzbekistan
  • Mukhtorov Alisher
    National University of Uzbekistan named after M. Ulugbek, 100174 Tashkent, Uzbekistan
  • Mаmаdаminоv Rаhmаtjоn
    Nаmаngаn Stаtе Univеrsitу. Namangan region, Namangan, 160119, Uzbekistan
  • Chanqayev O'ljaboy
    Uzbek State University of Physical Culture and Sport, 111709 Chirchik, Uzbekistan
  • Yuldasheva Nargiza
    S.Yu. Yunusov Institute of Chemistry of Plant Substances, Academy of Science s of the Republic of Uzbekistan, 100170 Tashkent, Uzbekistan
Scutellarin platelet aggregation coagulation

Background: Scutellarin, a flavonoid-rich compound derived from Erigeron breviscapus–related plant material, has been reported to exert cardiovascular and antithrombotic effects, but its integrated influence on platelet–coagulation hemostasis remains incompletely characterized. Methods: we analyzed the in vitro effects of scutellarin on thrombin time (TT), activated recalcification time (ART), activated partial thromboplastin time (APTT), prothrombin time (PT), and ADP-induced platelet aggregation, as well as its effects on intracellular Ca2+ signaling in platelets. Results: Scutellarin prolonged TT, ART, APTT, and PT in a concentration-dependent manner, indicating a broad anticoagulant profile spanning both intrinsic and extrinsic/common coagulation pathways. TT increased from a baseline range of 18–25 s to as high as 140 s at 50 μM, while PT reached approximately 85 s at the upper tested concentrations. In platelet studies, scutellarin strongly inhibited the second phase of ADP-induced aggregation and attenuated ADP-evoked intracellular Ca2+ rise by approximately 16–19% without behaving as a simple extracellular Ca2+ chelator. Platelet counts were not significantly reduced. Conclusions: The available experimental data support scutellarin as a multitarget modulator of platelet–coagulation hemostasis with both antiplatelet and anticoagulant properties. The pattern of response is consistent with interference at several levels, including thrombin/fibrin formation, coagulation-complex assembly on phosphatidylserine-rich membranes, and receptor-linked platelet Ca2+ signaling.

Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958–965.

Mackman N. Triggers, targets and treatments for thrombosis. Nature. 2008;451(7181):914–918.

Jackson SP. The growing complexity of platelet aggregation. Blood. 2007;109(12):5087–5095.

Ruggeri ZM. Platelet adhesion under flow. Microcirculation. 2009;16(1):58–83.

Varga-Szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thromb Haemost. 2009;7(7):1057–1066.

Reddy EC, Rand ML. Procoagulant phosphatidylserine-exposing platelets in vitro and in vivo. Front Cardiovasc Med. 2020;7:15.

Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013;93(1):327–358.

Ng VL. Prothrombin time and partial thromboplastin time assay considerations. Clin Lab Med. 2009;29(2):253–263.

Hemker HC, Al Dieri R, De Smedt E, Béguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost. 2006;96(5):553–561.

Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119(1 Suppl):64S–94S.

Mackie I, Casini A, Pieters M, et al. International Council for Standardisation in Haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders. Int J Lab Hematol. 2024;46(1):20–32.

Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost. 2001;86(1):222–232.

Gilio K, van Kruchten R, Braun A, et al. Roles of platelet STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem. 2010;285(31):23629–23638.

Fujii T, Sakata A, Nishimura S, Eto K, Nagata S. TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets. Proc Natl Acad Sci U S A. 2015;112(41):12800–12805.

Mozzicafreddo M, Cuccioloni M, Eleuteri AM, Fioretti E, Angeletti M. Flavonoids inhibit the amidolytic activity of human thrombin. Biochimie. 2006;88(9–10):1297–1306.

Bijak M, Ponczek MB, Nowak P. Polyphenol compounds belonging to flavonoids inhibit activity of coagulation factor X. Int J Biol Macromol. 2014;65:129–135.

Gao J, Chen G, He H, Liu C, Xiong X, Li J, Wang J. Therapeutic effects of breviscapine in cardiovascular diseases: a review. Front Pharmacol. 2017;8:289.

Tian X, Chang L, Ma G, Wang T, Lv M, Wang Z, Chen L, Wang Y, Gao X, Zhu Y. Delineation of platelet activation pathway of scutellarein revealed its intracellular target as protein kinase C. Biol Pharm Bull. 2016;39(2):181–191.

Scheraga HA. The thrombin–fibrinogen interaction. Biophysical Chemistry. 2004;112(2–3):117–130.

Shi ZH, Li NG, Shi QP, Tang YP, Yang JP, Duan JA. Synthesis of scutellarein derivatives to increase biological activity and water solubility. Bioorganic & Medicinal Chemistry Letters. 2015;25(20):4382–4386.

Soulet C, Hechler B, Gratacap MP, Plantavid M, Offermanns S, Gachet C, Payrastre B. A differential role of the platelet ADP receptors P2Y1 and P2Y12 in Rac activation. Journal of Thrombosis and Haemostasis. 2005;3(10):2296–2306.

Khoshimov, N. N., Mukhtorov, A. A., Nasirov, K. E., Rakhimov, R. N., & Mamadaminov, R. R. (2022). Effeсts of Рolyрhenols on Сhanges in the Transрort of Сa2+ NMDA-reсeрtors Under the Influenсe of L-glutamate against the Baсkground of Alzheimer’s Disease. Journal of Рharmaceutical Negative Results, 13, 1322-1332.

Khoshimov, N. N., Nasirov, K. E., Raimova, G. M., Musaeva, M. K., Azizov, V. G., Тuraev AS, M. S., ... & Abdusalоmоv Sh, A. (2021). Study of the effect of polysaccharides on hemostasis. The American journal of medical sciences and pharmaceutical research, 3(01), 131-138.

Khoshimov, N. N., Mukhtorov, A. A., Nasirov, K. E., Rakhimov, R. N., & Mamadaminov, R. R. (2022). Effeсts оf Pоlyphenоls оn Сhаnges in the Trаnspоrt оf Са2+ NMDА-reсeptоrs Under the Influenсe оf L-glutаmаte аgаinst the Bасkgrоund оf Аlzheimer’s Diseаse. Journal of Pharmaceutical Negative Results, 1322-1332.

Nasirov, K. E., Musaeva, M. K., Khoshimov, N. N., Raimova, G. M., Turaev, A. S., & Muhitdinov, B. I. (2020). Influence of some sulphated polysaccharides on the platelet aggregation in normal and in patients with ischemic heart disease. International Journal of Psychosocial Rehabilitation, 24(8), 6976-6985.

Ugli, D. J. I., Bakhtiyarovich, K. I., Numonjonovich, K. N., Erkinovich, N. K., Madmuradovna, R. G., Abdugaparovich, M. A., ... & Raxmankulovna, A. N. (2025). The Influence of Polyphenols on Calcium Dynamics in Synaptosomes of Model Rats with Attention Deficit Hyperactivity Disorder of Varying Ages. Trends in Sciences, 22(9), 10434-10434.

Numonjonovich, K. N., Baxtiyarovich, K. I., Ugli, D. J. I., Salimovich, K. S., Ugli, M. A. A., Ugli, O. M. M., ... & Nurillayevich, R. R. (2024). Еffесt of Pоlyphеnоls on Сhаngеs in thе Hеmоstаtiс Systеm of Blооd Plаsmа in Hеаlthy and Mоdеl Rаts with Аlzhеimеr’s Disеаsе. Trends in Sciences, 21(9), 8081-8081.

Khoshimov, N. N., Mamatova, M. S., Ortikov, M. M., & Eshonov, M. A. (2021). The action of the alkaloid acuzun on the functional activity of platelets. Materials of the V International Scientific and Practical Conference" Medical drugs for humans. Modern issues of pharmacotherapy and prescription of medicine".

Mukhtorov, A. A., Khoshimov, N. N., Nasirov, K. E., Saatov, T. S., Mustafakulov, M. A., Dedaboev, J. I., ... & Madaminov, R. R. (2024). Changes in the regulation of Ca2+ signaling in synaptosomes in Alzheimer’s disease. SPAST Abstracts, 2, 5045.

Khoshimov, N. N., Mukhtorov, A. A., Nasirov, K. E., Rаkhimоv, R. N., Mustafakulov, M. A., Dedaboev, J. I., ... & Madaminov, R. R. (2024). Rеgulation and corrеction with thе hеlp of polуphеnols to changе thе dуnamics of transport of Ca2+ NMDA-rеcеptors in thе statе of Alzhеimеr’s disеasе. SPAST Abstracts, 2, 5042.